Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |